ERBB2 and biliary tract neoplasm: The oncogene ERBB2, commonly known as HER2 (human epidermal growth factor receptor 2), is being evaluated as a precision medicine target in biliary tract cancer (Koeberle and Fritsch 2021; Bogenberger et al. 2018).